Home
Stewards of critical care
FOCUS
Addressing urgent needs
We are uniquely positioned to combat serious conditions and advance innovative treatment options in areas of high unmet need
Critical Care
Infectious Diseases
Global Mission
Our marketed products
Grounded in thorough research and a rigorous commitment to quality, our therapies include new, as well as established standards for critical care and infectious disease treatments.
Learn More
GIAPREZA®
(angiotensin II)
XERAVA®
(eravacycline)
XACDURO®
(sulbactam for injection; durlobactam for injection)
Development pipeline
ZOLIFLODACIN
Company
An enduring influence
A growing and diversified biotechnology company, we are building a culture dedicated to delivering products that help save lives
Leadership
Led by a mission-driven team that blends rigorous medical science with the latest advances in pharmaceutical innovation
Learn More
Careers
Join a team where all colleagues can do their best work while making a lasting impact
Learn More